COVID-19 and dermal fillers in orofacial harmonization
DOI:
https://doi.org/10.33448/rsd-v12i7.42395Keywords:
COVID-19 Vaccines; Dermal fillers; Inflammation mediators.Abstract
The search for aesthetic procedures has increased due to several factors in modern society, leading people to seek improvements through non-invasive procedures, such as orofacial harmonization (HOF) performed by dentists (CD). Hyaluronic Acid (HA) is currently considered one of the best fillers, since it is a substance naturally present in human skin, although its amount decreases over the years. Filling with HA can provide positive results, softening aging lines and improving facial contour. However, it is important to highlight the relationship between COVID-19 and the use of dermal fillers. Based on a narrative review and analysis of data available in the literature, it was concluded that COVID-19 may increase the risk of developing a rare but potentially serious complication called Persistent Intermittent Delayed Edema (IPTE) after the use of dermal fillers. Recent studies suggest that the virus can cause systemic inflammation and changes in blood clotting, which increases the risk of complications after the application of fillers. Therefore, it is critical that healthcare professionals are aware of the potential risks and take precautions to minimize patient exposure. It is also necessary to carefully assess the patients' medical history prior to the dermal filler procedure in order to identify possible risk factors for the development of ETIP. The objective of this research is, through a narrative review of the literature about the relationship between COVID-19 and the use of dermal fillers, especially in the HOF specialty.
References
Ballin, A. C., Brandt, F., & Cazzaniga, A. (2015). Dermal Fillers: An Update. American Journal of Clinical Dermatology, 271-283.
Baptista, A., & Fernandes, L. (2020). COVID-19, análisis de las estrategias de prevención, cuidados y complicaciones sintomáticas. Revista Desafios, 39-46.
Barbosa, K., et al. (2021). Diretrizes em harmonização orofacial para abordagem de tratamentos minimamente invasivos durante a pandemia COVID-19. Revista Eletrônica Acervo Saúde, 1-10.
Carneiro, N., et al. (2022). Intercorrências clínicas no uso de preenchedores faciais e suas implicações anatômicas na odontologia. Variações Anatômicas. 2, 89-98.
Cavallieri, F., et al. (2017). Edema tardio intermitente e persistente ETIP: reação adversa tardia ao preenchedor de ácido hialurônico. Surgical & Cosmetic Dermatology, 218-222.
Ferreira, J. C., & Sousa, L. T. (2021). Ácido hialurônico e suas aplicações na harmonização orofacial: revisão de literatura. Repositório UNITAU, 2-54.
Filho, P., et al. (2021). Vacinas contra Coronavírus (COVID-19; SARS-COV-2) no Brasil: um panorama geral. Research, Society and Development, 1-11.
Girardi, J., et al. (2021). Uso de máscaras para a redução da transmissão da COVID-19. Com. Ciências Saúde, 17-30.
López Pérez V. (2022). COVID-19 and Dermal Fillers: Should We Really Be Concerned? COVID y rellenos faciales ¿realmente debemos preocuparnos? Actas dermo-sifiliograficas, 113(9), 888–894.
Magno, L., et al. (2020). Desafios e propostas para ampliação da testagem e diagnóstico para COVID-19 no Brasil. Ciência & saúde coletiva, 3355-3364.
Maia, I., & Salvi, J. (2018). O uso do ácido hialurônico na harmonização facial: uma breve revisão. Brazilian Journal of Surgery and Clinical Research-BJSCR, 135-139.
Mangaro, N., Pereira, J., & Silva, R. (2022). Complicações em procedimentos de harmonização orofacial: uma revisão sistemática. Revista Brasileira de Cirurgia Plástica, 204-217.
Mendes, A. (2022). Edema Tardio Intermitente e Persistente. Faculdade Sete Lagoas - FACSETE, 1-24.
Mira, J. K. de S., & Cartágenes, S. C. (2023). Hyaluronic acid and the various pharmaceutical formulations in aging. Research, Society and Development, 12(5), e27812541806.
Munavalli, G. G., Guthridge, R., Knutsen-Larson, S., Brodsky, A., Matthew, E., & Landau, M. (2022). "COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment". Archives of dermatological research, 314(1), 1–15.
Oliveira, E. N., Costa, M. S. A., Nascimento, P. I. Da F. V. Do, Rodrigues, C. S., Andrade, C. S. G. De, Mendonça, J. M. F., Pinto, M. R., França, S. Sa S., & Lima, G. F. (2020). With the word, health professionals who are at the front line of COVID-19 combat. Research, Society and Development, 9(8), e30985145.
Pereira, J., & Atra, M. (2020). Harmonização orofacial: ácido hialurônico e possíveis complicações. UNITAU, 1-49.
Pessim, G., & Marchetti, P. (2020). O ácido hialurônico como preenchedor facial: uma revisão bibliográfica. Fundação de Ensino e Pesquisa do Sul de Minas, 1-19.
Reis, V., & Bello, L. (2021). Fototerapia no tratamento de reações em preenchimento com ácido hialurônico após vacinação contra o COVID-19. Aesthetic Orofacial Science, 102-109.
Rother, E. T. (2007). Revisão sistemática x revisão narrativa. Acta Paul. Enferm, 20(2).
Vasconcelos, S., et al. (2020). O uso do ácido hialurônico no rejuvenescimento facial. Revista Brasileira Militar de Ciências, 8-15.
Veloso, P., et al. (2022). ETIP-edema tardio intermitente persistente após preenchimento com ácido hialurônico: uma revisão de literatura. Revista Ibero-Americana de Humanidades, Ciências e Educação, 1988-2002.
Xavier, A. (2020). Clinical and laboratory manifestations in novel coronavirus infection. Jornal Brasileiro de Patologia e Medicina Laboratorial, 1-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Alinne Alves de Jesus; Roberto Teruo Suguihara; Daniella Pilon Muknicka
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
